Anti-influenza M2e antibody
Patent
·
OSTI ID:1034171
- Santa Fe, NM
Humanized recombinant and monoclonal antibodies specific for the ectodomain of the influenza virus M2 ion channel protein are disclosed. The antibodies of the invention have anti-viral activity and may be useful as anti-viral therapeutics and/or prophylactic/vaccine agents for inhibiting influenza virus replication and for treating individuals infected with influenza.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC52-06NA25396
- Assignee:
- Los Alamos National Security, LLC (Los Alamos, NM)
- Patent Number(s):
- 8,080,244
- Application Number:
- 12/592,241
- OSTI ID:
- 1034171
- Country of Publication:
- United States
- Language:
- English
Effects of humanization by variable domain resurfacing on the antiviral activity of a single-chain antibody against respiratory syncytial virus
|
journal | April 1999 |
Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus☆
|
journal | July 2006 |
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models
|
journal | January 2007 |
Similar Records
Anti-influenza M2e antibody
A humanized anti-M2 scFv shows protective in vitro activity against influenza
Patent
·
Tue Apr 16 00:00:00 EDT 2013
·
OSTI ID:1083632
A humanized anti-M2 scFv shows protective in vitro activity against influenza
Journal Article
·
Mon Dec 31 23:00:00 EST 2007
· Protein Engineering Design and Selection
·
OSTI ID:960849